S145 Week 24 Efficacy and Safety Data from PRISM3: A Randomized, Placebo-Controlled Trial Evaluating CP101, an Investigational Orally Administered Microbiome Therapeutic for the Prevention of Recurrent C. difficile Infection

Authors :: Thomas J. Louie
Richard Nathan
Ian Davis
John Pullman
Shrish Budree
Zain Kassam
Sahil Khanna
Thomas J. Borody
Sarah K. McGill
Robert Orenstein
Najwa El-Nachef
Jeff S. Bullock
Colleen R. Kelly
Michael Silverman
Facg
Ari Grinspan
Jessica R. Allegretti
Monika Fisher
Nicholas W. Van Hise
Darrell S. Pardi
Eugene F. Yen
Susy Hota
Colleen S. Kraft
Misra Bg
Source :: American Journal of Gastroenterology. 116:S63-S64
Publication Year :: 2021
Publisher :: Ovid Technologies (Wolters Kluwer Health), 2021.

Subjects :: medicine.medical_specialty
Hepatology
business.industry
Internal medicine
Gastroenterology
medicine
Placebo-controlled study
Microbiome
C difficile
business

Tools